Skip to main content

Table 2 Raw unadjusted total and incremental costs and QALYs following standard care and FFR management

From: Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods

 

Standard care

FFR

Difference

Mean (95 % CI)

Mean (95 % CI)

Mean (95 % CI)

Cost (£)

 Pressure wire

0 (0–0)

279 (273–287)

279 (273–287)

 PCI

837 (750–932)

766 (689–844)

−72 (−193 to 45)

 CABG

346 (174–550)

314 (143–487)

−32 (−292 to 226)

 Medications

59 (48–71)

49 (38–60)

−17 (−42 to 7)

 Cath lab time

1806 (1672–1949)

1864 (1770–1962)

57 (−114 to 221)

 Length of stay

4435 (4043–4847)

4104 (3595–4673)

−331 (−1002 to 356)

 Other procedures

125 (117–132)

134 (127–141)

9 (−1 to 20)

 Events during index year

956 (613–1372)

713 (468–982)

−243 (−736 to 200)

Total cost (£)

8565 (7872–9304)

8222 (7518–8985)

−349 (−1367 to 675)

Total QALYs

0.801 (0.765–0.835)

0.82 (0.787–0.845)

0.02 (−0.029 to 0.061)